F. N. Al‐Refaie

989 total citations
14 papers, 690 citations indexed

About

F. N. Al‐Refaie is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, F. N. Al‐Refaie has authored 14 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 12 papers in Hematology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in F. N. Al‐Refaie's work include Hemoglobinopathies and Related Disorders (11 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (4 papers). F. N. Al‐Refaie is often cited by papers focused on Hemoglobinopathies and Related Disorders (11 papers), Iron Metabolism and Disorders (8 papers) and Pharmacological Effects and Toxicity Studies (4 papers). F. N. Al‐Refaie collaborates with scholars based in United Kingdom, Canada and Switzerland. F. N. Al‐Refaie's co-authors include A. V. Hoffbrand, B. Wonke, D. G. Wickens, C Hershko, Nancy F. Olivieri, Eva Prescott, Mehrnoush Kosaryan, Bernard A. Davis, L Sheppard and George J. Kontoghiorghes and has published in prestigious journals such as The Lancet, Blood and Hepatology.

In The Last Decade

F. N. Al‐Refaie

14 papers receiving 650 citations

Peers

F. N. Al‐Refaie
M. A. Aldouri United Kingdom
MJ Pippard United Kingdom
Joan Henthorn United Kingdom
M Laulicht United Kingdom
Victor Hoffbrand United Kingdom
M. A. Aldouri United Kingdom
F. N. Al‐Refaie
Citations per year, relative to F. N. Al‐Refaie F. N. Al‐Refaie (= 1×) peers M. A. Aldouri

Countries citing papers authored by F. N. Al‐Refaie

Since Specialization
Citations

This map shows the geographic impact of F. N. Al‐Refaie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. N. Al‐Refaie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. N. Al‐Refaie more than expected).

Fields of papers citing papers by F. N. Al‐Refaie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. N. Al‐Refaie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. N. Al‐Refaie. The network helps show where F. N. Al‐Refaie may publish in the future.

Co-authorship network of co-authors of F. N. Al‐Refaie

This figure shows the co-authorship network connecting the top 25 collaborators of F. N. Al‐Refaie. A scholar is included among the top collaborators of F. N. Al‐Refaie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. N. Al‐Refaie. F. N. Al‐Refaie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Al‐Refaie, F. N., et al.. (2016). A District General Hospital Experience of Patients Receiving Apixaban, Dabigatran, Rivaroxaban or Warfarin for Anticoagulation. Blood. 128(22). 4733–4733. 2 indexed citations
2.
Hoffbrand, A. V., et al.. (1998). Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients. Blood. 91(1). 295–300. 163 indexed citations
3.
Hoffbrand, A. V., et al.. (1998). Long-Term Trial of Deferiprone in 51 Transfusion-Dependent Iron Overloaded Patients. Blood. 91(1). 295–300. 7 indexed citations
4.
Al‐Refaie, F. N., L Sheppard, P. Nortey, B. Wonke, & A. V. Hoffbrand. (1995). Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. British Journal of Haematology. 89(2). 403–408. 78 indexed citations
5.
Al‐Refaie, F. N., et al.. (1995). Changes in transferrin saturation after treatment with the oral iron chelator deferiprone in patients with iron overload.. Journal of Clinical Pathology. 48(2). 110–114. 13 indexed citations
6.
Al‐Refaie, F. N., C Hershko, A. V. Hoffbrand, et al.. (1995). Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron Chelators. British Journal of Haematology. 91(1). 224–229. 145 indexed citations
7.
Cunningham, John M., F. N. Al‐Refaie, Ann E. Hunter, L Sheppard, & A. V. Hoffbrand. (1994). Differential toxicity of α‐keto hydroxypyridine iron chelators and desferrioxamine to human haemopoietic precursors in vitro. European Journal Of Haematology. 52(3). 176–179. 19 indexed citations
8.
Al‐Refaie, F. N., B. Wonke, & A. V. Hoffbrand. (1994). Deferiprone‐associated myelotoxicity. European Journal Of Haematology. 53(5). 298–301. 60 indexed citations
9.
Al‐Refaie, F. N. & A. V. Hoffbrand. (1994). 10 Oral iron-chelating therapy: the L1 experience. Baillière s Clinical Haematology. 7(4). 941–963. 15 indexed citations
10.
Al‐Refaie, F. N., B. Wonke, A. V. Hoffbrand, & N F Olivieri. (1994). Arthropathy in thalassaemia patients receiving deferiprone. The Lancet. 344(8917). 262–263. 5 indexed citations
11.
Al‐Refaie, F. N., et al.. (1994). Zinc concentration in patients with iron overload receiving oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one or desferrioxamine.. Journal of Clinical Pathology. 47(7). 657–660. 50 indexed citations
12.
Dixon, Ruth, Peter Styles, F. N. Al‐Refaie, et al.. (1994). Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy. Hepatology. 19(4). 904–910. 31 indexed citations
13.
Al‐Refaie, F. N., et al.. (1994). The effect of deferiprone (L1) and desferrioxamine on myelopoiesis using a liquid culture system. British Journal of Haematology. 87(1). 196–198. 16 indexed citations
14.
Al‐Refaie, F. N., D. G. Wickens, B. Wonke, George J. Kontoghiorghes, & A. V. Hoffbrand. (1992). Serum non‐transferrin‐bound iron in beta‐thalassaemia major patients treated with desferrioxamine and L1. British Journal of Haematology. 82(2). 431–436. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026